- Home
- BL vs ASTH Comparison
BL vs ASTH Comparison
Compare BL & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BL | ASTH |
|---|---|---|
| Founded | 2001 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Professional Services |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2016 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BL | ASTH |
|---|---|---|
| Price | $28.44 | $37.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $56.62 | $34.86 |
| AVG Volume (30 Days) | ★ 1.5M | 412.7K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.13 | ★ 0.29 |
| Revenue | $177,031,000.00 | ★ $519,907,752.00 |
| Revenue This Year | $12.62 | $27.38 |
| Revenue Next Year | $10.90 | $10.78 |
| P/E Ratio | $220.85 | ★ $130.52 |
| Revenue Growth | 43.78 | ★ 45.90 |
| 52 Week Low | $24.70 | $18.08 |
| 52 Week High | $59.57 | $39.93 |
Technical Indicators
Market Signals| Indicator | BL | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 45.60 | 58.90 |
| Support Level | $25.49 | $36.95 |
| Resistance Level | $30.93 | $39.93 |
| Average True Range (ATR) | 1.96 | 1.19 |
| MACD | 0.21 | -0.44 |
| Stochastic Oscillator | 41.75 | 51.47 |
Price Performance
Historical ComparisonAbout BL BlackLine Inc.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.
About ASTH Astrana Health Inc.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.